The COVID-19 pandemic has caused rising anxiety and a corresponding increase in benzodiazepine prescriptions. Experts worry that inconsistent access to physicians as a result of stay-at-home orders will lead dependent patients to seek counterfeit or street drugs if their prescriptions lapse. This brief discusses these repercussions and recommends approaches to monitor and support those suffering from anxiety.
anxiety, COVID19, coronavirus, anti-anxiety drugs, prescription drugs, mental health
Psychiatric and Mental Health | Substance Abuse and Addiction
For More Information
The authors would like to thank Megan Ray and Shannon Monnat for edits on previous drafts.
Atlas, Noah and McNeill Brown, Austin, "Anxious Times and Anxiety Drugs" (2021). Lerner Center for Public Health Promotion: Population Health Research Brief Series. 113.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.